2008
DOI: 10.1016/j.bmc.2008.04.006
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis, and application of novel triclosan prodrugs as potential antimalarial and antibacterial agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
18
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
5
1
1

Relationship

2
5

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 32 publications
0
18
0
Order By: Relevance
“…Average-sum FIC 50 was determined by the sum of the ratio of the IC 50 of each drug in combination treatments over the IC 50 of each of the drug administered alone. Synergistic activity was defined by a sum FIC ratio of Յ0.5 according to previously published definitions (4,13,21).…”
Section: Methodsmentioning
confidence: 99%
“…Average-sum FIC 50 was determined by the sum of the ratio of the IC 50 of each drug in combination treatments over the IC 50 of each of the drug administered alone. Synergistic activity was defined by a sum FIC ratio of Յ0.5 according to previously published definitions (4,13,21).…”
Section: Methodsmentioning
confidence: 99%
“…In continuation of earlier work by several groups of investigators, this study further explores the B-ring of triclosan, focusing specifically on its 2 0 -position and the intricate molecular interactions using docking analysis (6,7,15,19). The chloro group at 2 0 -position of triclosan is shown to have close proximity to Ala 217 and pyrophosphate moiety of NAD 1 .…”
Section: Introductionmentioning
confidence: 88%
“…In type II FAS each reaction of fatty acid synthesis is catalyzed by a physically distinct enzyme in contrast to a single multifunctional enzyme in type I FAS that catalyzes all the required reactions (5). Because of these differences in the organization of the type I and type II FAS, the latter is considered to be suitable as a target for developing antimicrobial and antiparasitic agents as well as vaccines against the organisms (6,7).…”
Section: Introductionmentioning
confidence: 99%
“…1. In this context, several triclosan analogs were designed by our group (23)(24)(25) and we have also discovered that rhodanines are potent inhibitors of PfENR (26). Triclosan is also shown to be potent against Plasmodium berghei in vivo mice infections (3) and in vitro human cells (27).…”
Section: Introductionmentioning
confidence: 99%